Cargando…
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
Autores principales: | Alexander, James L, Selinger, Christian P, Powell, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511687/ https://www.ncbi.nlm.nih.gov/pubmed/34653395 http://dx.doi.org/10.1016/S2468-1253(21)00374-5 |
Ejemplares similares
-
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021) -
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022) -
Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)